Ricky Bassi, MD
Endocrinology · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
- Since medical school
- 22 years
- University of Florida College of Medicine, 2004
Offices
1 location · First Choice Physician Partners · 130 clinicians in this group
Hospitals listed: Adventist Health Sonora · Emanuel Medical Center · Memorial Medical Center · Oak Valley Hospital District. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bassi’s office at (209) 577-3388 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
California Medical Board record
Licence A125244 · Current
Licensed to practise in California · since 2013 · expires 2027-04-30 · University of Florida College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Oak Valley Hospital DistrictOakdale, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Adventist Health Sonora
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative wound dehiscence rateComplications and deaths | 3.5 (2.04 to 4.96) · 288 cases | Worse | Jul 2022 – Jun 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 1,004 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 582 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.5 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.91 (123.44 to 242.37) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 236 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 433 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,671 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,602 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.24 to 5.59) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.97 (0 to 16.16) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (1.85 to 9.58) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.06) · 2,750 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.614 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.8 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 381 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.3 to 8.1) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.1 to 14.7) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.3) · 1,835 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Oak Valley Hospital District
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.47 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 19.1 · 41 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 122 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 387 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 391 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.58 (0 to 1.88) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Hospital return days for heart failure patientsUnplanned return visits | 113.4 · 27 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 48.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.7) · 186 cases | No different | Jan 2022 – Dec 2024 |
Original Medicare doctor bills
$80,219
Medicare paid this office $80,219 for 376 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 223 | $28,970 | $87 |
| Injection, denosumab, 1 mg | 12 | $22,447 | None |
| Short return visit (20+ min) | 167 | $12,119 | $61 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 82 | $3,554 | $26 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 213 | $3,173 | $11 |
See all 11 services
| Return visit (30+ min) | 223 | $28,970 | $87 |
| Injection, denosumab, 1 mg | 12 | $22,447 | None |
| Short return visit (20+ min) | 167 | $12,119 | $61 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 82 | $3,554 | $26 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 213 | $3,173 | $11 |
| New patient visit (45+ min) | 23 | $2,354 | $102 |
| New patient visit (60+ min) | 14 | $2,121 | $152 |
| Ultrasound scan of head and neck soft tissue | 16 | $1,305 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,236 | $65 |
| Injection of drug or substance under skin or into muscle | 13 | $233 | $12 |
| Hemoglobin a1c level | 21 | $209 | $10 |
Who their Medicare patients are
376 Original Medicare patients in 2024. Average age 69 · Under 65 15% · 85 and older 4% · Women 73% · Also on Medicaid 43% · Health risk score 1.38. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 56% · Chronic kidney disease 27% · Coronary heart disease 23% · Depression 22% · Cancer 16% · Heart failure 15% · Atrial fibrillation 14% · COPD 12% · Stroke 6% · Dementia 4%.
The office billed $260,713, Medicare allowed $113,147 and paid $80,219; for 2,168 services of 15 kinds; $22,447 of it was for drugs given in the office and $57,772 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 376 | 2,168 | 69 | 1.38 | $260,713 | $80,219 |
| 2023 | 328 | 1,996 | 70 | 1.34 | $235,012 | $70,190 |
| 2022 | 381 | 2,013 | 69 | 1.53 | $246,371 | $73,450 |
| 2021 | 390 | 1,689 | 69 | 1.58 | $243,258 | $82,555 |
| 2020 | 341 | 1,236 | 69 | 1.68 | $192,226 | $54,713 |
| 2019 | 330 | 1,163 | 69 | 1.72 | $182,871 | $51,197 |
| 2018 | 358 | 1,143 | 68 | 1.84 | $206,412 | $61,671 |
| 2017 | 317 | 856 | 67 | 1.62 | $157,950 | $46,773 |
| 2016 | 285 | 1,055 | 67 | 1.59 | $142,825 | $40,790 |
| 2015 | 253 | 932 | 68 | 1.37 | $163,733 | $52,457 |
| 2014 | 163 | 690 | 70 | 1.45 | $125,912 | $44,002 |
| 2013 | 100 | 170 | 66 | 1.67 | $46,663 | $12,889 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 205 | $27,031 | $88 |
| Injection, denosumab, 1 mg | 14 | $23,980 | None |
| Short return visit (20+ min) | 121 | $7,894 | $59 |
| Long return visit (40+ min) | 19 | $2,615 | $138 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 47 | $2,017 | $26 |
| New patient visit (45+ min) | 15 | $1,569 | $105 |
| Ultrasound scan of head and neck soft tissue | 15 | $1,197 | $75 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $992 | $31 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $735 | $61 |
| Injection of drug or substance under skin or into muscle | 17 | $256 | $9 |
| Hemoglobin a1c level | 19 | $181 | $10 |
2022: 12 services
| Return visit (30+ min) | 229 | $26,600 | $84 |
| Injection, denosumab, 1 mg | 12 | $21,069 | None |
| Short return visit (20+ min) | 111 | $6,545 | $54 |
| New patient visit (45+ min) | 34 | $4,058 | $119 |
| New patient visit (60+ min) | 29 | $3,489 | $120 |
| Long return visit (40+ min) | 26 | $3,351 | $116 |
| Telephone medical discussion with physician, 11-20 minutes | 43 | $2,766 | $60 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,940 | $88 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 36 | $1,485 | $26 |
| Ultrasound scan of head and neck soft tissue | 13 | $812 | $62 |
| Injection of drug or substance under skin or into muscle | 19 | $478 | $10 |
| Hemoglobin a1c level | 23 | $230 | $10 |
2021: 12 services
| Return visit (30+ min) | 207 | $27,969 | $98 |
| Short return visit (20+ min) | 157 | $11,415 | $63 |
| New patient visit (60+ min) | 46 | $7,359 | $160 |
| Long return visit (40+ min) | 41 | $5,445 | $133 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $4,183 | $107 |
| New patient visit (45+ min) | 33 | $3,862 | $117 |
| Telephone medical discussion with physician, 11-20 minutes | 55 | $3,860 | $63 |
| Ultrasound scan of head and neck soft tissue | 16 | $1,458 | $91 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 30 | $1,184 | $27 |
| Telephone medical discussion with physician, 5-10 minutes | 23 | $709 | $28 |
| Injection of drug or substance under skin or into muscle | 17 | $334 | $12 |
| Hemoglobin a1c level | 34 | $330 | $9 |
2020: 13 services
| Return visit (30+ min) | 151 | $16,317 | $77 |
| Short return visit (20+ min) | 203 | $13,779 | $51 |
| New patient visit (60+ min) | 24 | $3,251 | $135 |
| New patient visit (45+ min) | 25 | $3,033 | $121 |
| Telephone medical discussion with physician, 11-20 minutes | 38 | $2,947 | $60 |
| Ultrasound scan of head and neck soft tissue | 24 | $2,220 | $79 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,754 | $92 |
| Long return visit (40+ min) | 13 | $1,603 | $114 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 13 | $605 | $28 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $465 | $36 |
| Hemoglobin a1c level | 25 | $260 | $10 |
| Injection of drug or substance under skin or into muscle | 11 | $206 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 25 | $77 | $3 |
2019: 9 services
| Return visit (30+ min) | 173 | $18,791 | $77 |
| Short return visit (20+ min) | 152 | $9,388 | $50 |
| Long return visit (40+ min) | 53 | $6,631 | $102 |
| New patient visit (60+ min) | 32 | $4,775 | $149 |
| New patient visit (45+ min) | 23 | $2,654 | $115 |
| Ultrasound scan of head and neck soft tissue | 19 | $1,608 | $77 |
| Blood glucose (sugar) test performed by hand-held instrument | 108 | $457 | $3 |
| Hemoglobin a1c level | 33 | $351 | $10 |
| Injection of drug or substance under skin or into muscle | 17 | $337 | $12 |
2018: 9 services
| Return visit (30+ min) | 191 | $21,339 | $75 |
| Long return visit (40+ min) | 108 | $15,397 | $105 |
| New patient visit (60+ min) | 59 | $7,981 | $135 |
| Short return visit (20+ min) | 125 | $7,870 | $50 |
| New patient visit (45+ min) | 30 | $3,470 | $116 |
| Ultrasound scan of head and neck soft tissue | 21 | $1,767 | $84 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 21 | $471 | $22 |
| Administration of influenza virus vaccine | 20 | $429 | $21 |
| Injection of drug or substance under skin or into muscle | 17 | $275 | $14 |
2017: 8 services
| Return visit (30+ min) | 147 | $15,368 | $75 |
| Short return visit (20+ min) | 141 | $8,589 | $49 |
| New patient visit (60+ min) | 43 | $5,990 | $139 |
| Long return visit (40+ min) | 45 | $5,328 | $102 |
| New patient visit (45+ min) | 44 | $5,191 | $118 |
| Ultrasound scan of head and neck soft tissue | 19 | $1,775 | $81 |
| Injection of drug or substance under skin or into muscle | 17 | $442 | $18 |
| Blood glucose (sugar) test performed by hand-held instrument | 29 | $89 | $3 |
2016: 11 services
| Short return visit (20+ min) | 141 | $10,252 | $52 |
| Return visit (30+ min) | 104 | $9,683 | $71 |
| New patient visit (60+ min) | 45 | $5,932 | $132 |
| New patient visit (45+ min) | 40 | $4,571 | $114 |
| Long return visit (40+ min) | 27 | $2,938 | $92 |
| New patient visit (30+ min) | 36 | $2,514 | $70 |
| Ultrasound scan of head and neck soft tissue | 22 | $2,200 | $81 |
| Short return visit | 26 | $813 | $28 |
| Blood glucose (sugar) test performed by hand-held instrument | 134 | $717 | $3 |
| Hemoglobin a1c level | 44 | $700 | $13 |
| Injection of drug or substance under skin or into muscle | 13 | $366 | $17 |
2015: 10 services
| Return visit (30+ min) | 101 | $12,084 | $82 |
| New patient visit (60+ min) | 63 | $9,848 | $156 |
| Short return visit (20+ min) | 105 | $7,256 | $57 |
| New patient visit (45+ min) | 54 | $6,537 | $121 |
| Long return visit (40+ min) | 45 | $6,455 | $108 |
| Ultrasound scan of head and neck soft tissue | 32 | $3,704 | $95 |
| New patient visit (30+ min) | 35 | $2,844 | $81 |
| Hemoglobin a1c level | 55 | $984 | $13 |
| Short return visit | 22 | $798 | $36 |
| Blood glucose (sugar) test performed by hand-held instrument | 113 | $700 | $3 |
2014: 8 services
| New patient visit (60+ min) | 81 | $12,487 | $154 |
| Long return visit (40+ min) | 52 | $8,922 | $110 |
| Return visit (30+ min) | 63 | $6,223 | $85 |
| New patient visit (45+ min) | 37 | $4,970 | $134 |
| Ultrasound scan of head and neck soft tissue | 35 | $4,508 | $100 |
| Short return visit (20+ min) | 17 | $1,311 | $60 |
| Hemoglobin a1c level | 45 | $740 | $13 |
| Blood glucose (sugar) test performed by hand-held instrument | 67 | $395 | $3 |
2013: 6 services
| New patient visit (60+ min) | 25 | $4,109 | $164 |
| New patient visit (45+ min) | 16 | $2,126 | $133 |
| Return visit (30+ min) | 35 | $2,120 | $59 |
| Ultrasound scan of head and neck soft tissue | 18 | $1,888 | $99 |
| Hemoglobin a1c level | 12 | $159 | $13 |
| Blood glucose (sugar) test performed by hand-held instrument | 15 | $63 | $3 |
Medicaid work
$59,935 in 2024
Medicaid paid $59,935 for 2,082 billed services this clinician did in 2024, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 651 | $39,294 |
| Short return visit (20+ min) | 334 | $13,571 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 242 | $7,070 |
| TOBACCO NON-USER | 338 | $0 |
| Medication list documented in medical record (COA) | 14 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 14 | $0 |
| BODY MASS INDEX DOCD | 57 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 211 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 221 | $0 |
| 2024 | 2,082 | 9 | 72 | $59,935 |
| 2023 | 3,013 | 9 | 99 | $54,001 |
| 2022 | 1,524 | 11 | 74 | $54,055 |
| 2021 | 1,086 | 4 | 59 | $49,946 |
| 2020 | 1,073 | 6 | 75 | $43,954 |
| 2019 | 955 | 4 | 51 | $37,427 |
| 2018 | 1,140 | 6 | 57 | $57,028 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 771 | $39,352 |
| Short return visit (20+ min) | 384 | $12,967 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 81 | $1,682 |
| TOBACCO NON-USER | 510 | $0 |
| Medication list documented in medical record (COA) | 255 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 257 | $0 |
| BODY MASS INDEX DOCD | 240 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 259 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 256 | $0 |
2022
| Return visit (30+ min) | 679 | $36,026 |
| Short return visit (20+ min) | 245 | $8,657 |
| New patient visit (60+ min) | 45 | $4,574 |
| New patient visit (45+ min) | 31 | $2,517 |
| Long return visit (40+ min) | 26 | $2,281 |
| TOBACCO NON-USER | 165 | $0 |
| Medication list documented in medical record (COA) | 67 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 67 | $0 |
| BODY MASS INDEX DOCD | 54 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 77 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 68 | $0 |
2021
| Return visit (30+ min) | 509 | $25,177 |
| Short return visit (20+ min) | 493 | $16,753 |
| New patient visit (60+ min) | 68 | $6,386 |
| New patient visit (45+ min) | 16 | $1,629 |
2020
| Short return visit (20+ min) | 589 | $17,220 |
| Return visit (30+ min) | 364 | $15,162 |
| New patient visit (60+ min) | 47 | $5,101 |
| New patient visit (45+ min) | 44 | $4,476 |
| New patient visit (30+ min) | 16 | $1,011 |
| Long return visit (40+ min) | 13 | $983 |
2019
| Return visit (30+ min) | 396 | $14,643 |
| Short return visit (20+ min) | 411 | $10,897 |
| New patient visit (60+ min) | 72 | $7,261 |
| Long return visit (40+ min) | 76 | $4,625 |
2018
| Return visit (30+ min) | 508 | $23,413 |
| Long return visit (40+ min) | 248 | $16,615 |
| Short return visit (20+ min) | 287 | $8,640 |
| New patient visit (60+ min) | 73 | $7,043 |
| New patient visit (45+ min) | 12 | $1,087 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 12 | $231 |
Drugs they prescribed that Part D paid
$2,701,652
Pharmacies billed $2,701,652 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,477 generic and 3,243 brand-name prescriptions · $2,701,652 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 357 | $526,022 | $1,473 |
| Jardiance | 377 | $452,077 | $1,199 |
| Rybelsus | 169 | $335,143 | $1,983 |
| Trulicity | 87 | $164,294 | $1,888 |
| Mounjaro | 59 | $89,854 | $1,523 |
See all 77 drugs
| Ozempic | 357 | $526,022 | $1,473 |
| Jardiance | 377 | $452,077 | $1,199 |
| Rybelsus | 169 | $335,143 | $1,983 |
| Trulicity | 87 | $164,294 | $1,888 |
| Mounjaro | 59 | $89,854 | $1,523 |
| Forteo | 19 | $79,649 | $4,192 |
| Toujeo Max Solostar | 74 | $71,454 | $966 |
| Humalog Kwikpen U-100 | 247 | $68,084 | $276 |
| Januvia | 56 | $63,651 | $1,137 |
| Farxiga | 56 | $57,942 | $1,035 |
| Basaglar Kwikpen U-100 | 112 | $56,213 | $502 |
| Teriparatide | 26 | $53,442 | $2,055 |
| Humulin N Kwikpen | 192 | $50,023 | $261 |
| Toujeo Solostar | 90 | $49,920 | $555 |
| Fiasp Flextouch | 42 | $46,551 | $1,108 |
| Tresiba Flextouch U-100 | 66 | $45,942 | $696 |
| Evenity (2 Syringes) | 13 | $32,884 | $2,530 |
| Tresiba Flextouch U-200 | 28 | $32,285 | $1,153 |
| Nano 2nd Gen Pen Needle | 266 | $30,659 | $115 |
| Lantus Solostar | 185 | $29,037 | $157 |
| Insulin Lispro Kwikpen U-100 | 80 | $21,749 | $272 |
| Novolog Mix 70-30 Flexpen | 27 | $20,351 | $754 |
| Humulin 70/30 Kwikpen | 33 | $18,782 | $569 |
| Novolin N Flexpen | 91 | $18,492 | $203 |
| Novolog Flexpen | 71 | $17,768 | $250 |
| Humalog Mix 75-25 | 17 | $16,484 | $970 |
| Levothyroxine | 828 | $13,667 | $17 |
| Humulin 70-30 | 50 | $9,971 | $199 |
| Lantus | 30 | $9,344 | $311 |
| Humalog | 34 | $8,800 | $259 |
| Omnipod Dash Pods (Gen 4) | 13 | $7,281 | $560 |
| Synthroid | 75 | $7,219 | $96 |
| Humalog Mix 75-25 Kwikpen | 21 | $7,057 | $336 |
| Testosterone | 19 | $6,477 | $341 |
| Humulin N | 42 | $6,009 | $143 |
| Admelog Solostar | 15 | $4,509 | $301 |
| Insulin Lispro Protamine Mix | 12 | $4,091 | $341 |
| Novolog | 11 | $3,807 | $346 |
| Droplet Pen Needle | 34 | $3,508 | $103 |
| Ultra-Fine Mini Pen Needle | 26 | $3,293 | $127 |
| Levemir Flexpen | 15 | $3,157 | $210 |
| Desmopressin Acetate | 17 | $2,837 | $167 |
| Methimazole | 152 | $2,821 | $19 |
| Metformin | 245 | $2,813 | $11 |
| Glimepiride | 172 | $2,472 | $14 |
| Humulin R | 15 | $2,357 | $157 |
| Insulin Lispro | 20 | $2,282 | $114 |
| Cabergoline | 22 | $2,206 | $100 |
| Insulin | 32 | $2,081 | $65 |
| Glipizide Er | 73 | $1,989 | $27 |
| Ultra-Fine Short Pen Needle | 16 | $1,918 | $120 |
| Alendronate | 126 | $1,765 | $14 |
| Glipizide | 136 | $1,578 | $12 |
| Ultra-Fine Nano Pen Needle | 23 | $1,530 | $67 |
| Gabapentin | 58 | $1,500 | $26 |
| Omega-3 Acid Ethyl Esters | 13 | $1,459 | $112 |
| Insulin | 33 | $1,393 | $42 |
| Pravastatin | 49 | $1,318 | $27 |
| Hydrocortisone | 21 | $1,306 | $62 |
| Metformin Hcl Er | 80 | $1,292 | $16 |
| Trueplus Pen Needle | 21 | $1,147 | $55 |
| Liothyronine | 14 | $962 | $69 |
| Atorvastatin | 97 | $919 | $9 |
| Simvastatin | 81 | $902 | $11 |
| Calcitriol | 33 | $832 | $25 |
| Lisinopril | 65 | $591 | $9 |
| Testosterone Cypionate | 25 | $575 | $23 |
| Losartan | 57 | $569 | $10 |
| Rosuvastatin | 30 | $529 | $18 |
| Benazepril | 18 | $231 | $13 |
| Lisinopril-Hydrochlorothiazide | 14 | $227 | $16 |
| Hydrochlorothiazide | 31 | $180 | $6 |
| Amlodipine Besylate | 22 | $161 | $7 |
| Tamsulosin | 14 | $133 | $9 |
| Lovastatin | 11 | $71 | $6 |
| Fluconazole | 11 | $34 | $3 |
| Atenolol | 11 | $16 | $1 |
Year by year
| 2024 | 6,287 | 785 | None | 52% | $2,701,652 |
| 2023 | 6,111 | 752 | None | 49% | $3,167,011 |
| 2022 | 6,145 | 768 | 0% (0) | 50% | $2,635,661 |
| 2021 | 5,797 | 725 | 0% (0) | 48% | $2,321,774 |
| 2020 | 5,316 | 672 | 0% (0) | 47% | $1,910,396 |
| 2019 | 4,766 | 644 | 0% (0) | 47% | $1,556,608 |
| 2018 | 5,185 | 668 | 0% (0) | 45% | $1,491,015 |
| 2017 | 5,367 | 637 | 0% (0) | 41% | $1,255,409 |
| 2016 | 5,245 | 572 | None | 40% | $1,037,377 |
| 2015 | 3,907 | 419 | None | 43% | $788,356 |
| 2014 | 1,789 | 235 | 0% (0) | 45% | $325,410 |
| 2013 | 160 | 50 | None | 39% | $15,453 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 73 drugs
| Jardiance | 350 | $458,101 | $1,309 |
| Ozempic | 197 | $302,536 | $1,536 |
| Rybelsus | 121 | $272,678 | $2,254 |
| Trulicity | 135 | $238,561 | $1,767 |
| Humalog Kwikpen U-100 | 216 | $191,764 | $888 |
| Humulin N Kwikpen | 194 | $148,896 | $768 |
| Lantus Solostar | 202 | $142,128 | $704 |
| Novolog Flexpen | 114 | $123,522 | $1,084 |
| Farxiga | 65 | $89,216 | $1,373 |
| Toujeo Max Solostar | 91 | $81,069 | $891 |
| Novolog Mix 70-30 Flexpen | 39 | $75,184 | $1,928 |
| Humalog Mix 75-25 Kwikpen | 38 | $74,392 | $1,958 |
| Novolin N Flexpen | 102 | $64,953 | $637 |
| Forteo | 13 | $55,431 | $4,264 |
| Humalog | 46 | $55,059 | $1,197 |
| Januvia | 40 | $53,680 | $1,342 |
| Mounjaro | 28 | $52,941 | $1,891 |
| Humulin 70-30 | 58 | $45,723 | $788 |
| Basaglar Kwikpen U-100 | 94 | $44,882 | $477 |
| Humulin N | 58 | $41,574 | $717 |
| Tresiba Flextouch U-100 | 51 | $37,496 | $735 |
| Toujeo Solostar | 67 | $36,842 | $550 |
| Nano 2nd Gen Pen Needle | 266 | $29,819 | $112 |
| Humalog Mix 50-50 Kwikpen | 15 | $27,457 | $1,830 |
| Fiasp Flextouch | 33 | $21,269 | $645 |
| Humulin 70/30 Kwikpen | 15 | $20,768 | $1,385 |
| Prolia | 11 | $18,582 | $1,689 |
| Levothyroxine | 836 | $18,361 | $22 |
| Invokana | 11 | $16,609 | $1,510 |
| Lantus | 19 | $16,188 | $852 |
| Insulin Lispro Kwikpen U-100 | 51 | $15,971 | $313 |
| Tresiba Flextouch U-200 | 12 | $15,157 | $1,263 |
| Levemir Flexpen | 30 | $14,943 | $498 |
| Testosterone | 30 | $14,372 | $479 |
| Synthroid | 65 | $7,532 | $116 |
| Glimepiride | 216 | $6,055 | $28 |
| Glipizide Er | 99 | $5,916 | $60 |
| Metformin | 274 | $5,590 | $20 |
| Droplet Pen Needle | 61 | $4,434 | $73 |
| Methimazole | 144 | $4,327 | $30 |
| Alendronate | 137 | $3,192 | $23 |
| Ultra-Fine Mini Pen Needle | 29 | $2,944 | $102 |
| Glipizide | 148 | $2,846 | $19 |
| Metformin Hcl Er | 81 | $2,407 | $30 |
| Atorvastatin | 93 | $2,214 | $24 |
| Cabergoline | 18 | $2,119 | $118 |
| Hydrocortisone | 27 | $2,074 | $77 |
| Ultra-Fine Nano Pen Needle | 26 | $1,971 | $76 |
| Gabapentin | 44 | $1,910 | $43 |
| Ulticare Pen Needle | 26 | $1,906 | $73 |
| Pravastatin | 62 | $1,815 | $29 |
| Ultra-Fine Short Pen Needle | 13 | $1,674 | $129 |
| Calcitriol | 31 | $1,591 | $51 |
| Omega-3 Acid Ethyl Esters | 14 | $1,499 | $107 |
| Insulin | 32 | $1,405 | $44 |
| Simvastatin | 77 | $1,196 | $16 |
| Liothyronine | 11 | $1,149 | $104 |
| Insulin | 21 | $1,093 | $52 |
| Lisinopril | 39 | $902 | $23 |
| Armour Thyroid | 13 | $832 | $64 |
| Sure Comfort Pen Needle | 14 | $738 | $53 |
| Rosuvastatin | 33 | $730 | $22 |
| Losartan | 43 | $691 | $16 |
| Fenofibrate | 11 | $677 | $62 |
| Testosterone Cypionate | 19 | $569 | $30 |
| Benazepril | 20 | $496 | $25 |
| Amlodipine Besylate | 25 | $425 | $17 |
| Terazosin | 12 | $364 | $30 |
| Lisinopril-Hydrochlorothiazide | 11 | $283 | $26 |
| Techlite Pen Needle | 13 | $274 | $21 |
| Hydrochlorothiazide | 38 | $250 | $7 |
| Pioglitazone | 14 | $218 | $16 |
| Vitamin D2 | 16 | $172 | $11 |
2022: 77 drugs
| Jardiance | 330 | $399,091 | $1,209 |
| Trulicity | 156 | $283,461 | $1,817 |
| Humalog Kwikpen U-100 | 173 | $136,745 | $790 |
| Rybelsus | 64 | $136,630 | $2,135 |
| Humulin N Kwikpen | 210 | $131,873 | $628 |
| Novolog Flexpen | 138 | $131,230 | $951 |
| Ozempic | 77 | $129,089 | $1,676 |
| Lantus Solostar | 220 | $126,267 | $574 |
| Novolog Mix 70-30 Flexpen | 65 | $89,942 | $1,384 |
| Humalog Mix 75-25 Kwikpen | 58 | $83,027 | $1,431 |
| Basaglar Kwikpen U-100 | 121 | $53,670 | $444 |
| Toujeo Solostar | 81 | $48,841 | $603 |
| Novolin N Flexpen | 89 | $47,393 | $533 |
| Humalog Mix 50-50 Kwikpen | 31 | $41,679 | $1,344 |
| Humulin 70-30 | 64 | $41,128 | $643 |
| Humalog | 34 | $40,348 | $1,187 |
| Januvia | 25 | $36,603 | $1,464 |
| Tresiba Flextouch U-100 | 53 | $35,432 | $669 |
| Humulin N | 57 | $35,112 | $616 |
| Farxiga | 23 | $34,383 | $1,495 |
| Xultophy 100-3.6 | 18 | $31,400 | $1,744 |
| Prolia | 20 | $30,756 | $1,538 |
| Humulin 70/30 Kwikpen | 42 | $27,325 | $651 |
| Novolog Mix 70-30 | 18 | $25,104 | $1,395 |
| Toujeo Max Solostar | 15 | $20,338 | $1,356 |
| Tresiba Flextouch U-200 | 14 | $19,559 | $1,397 |
| Nano 2nd Gen Pen Needle | 222 | $19,014 | $86 |
| Lantus | 23 | $18,239 | $793 |
| Levothyroxine | 806 | $17,946 | $22 |
| Insulin Lispro Kwikpen U-100 | 60 | $16,657 | $278 |
| Levemir Flextouch | 32 | $15,701 | $491 |
| Fiasp Flextouch | 18 | $12,653 | $703 |
| Synthroid | 89 | $9,990 | $112 |
| Testosterone | 14 | $9,478 | $677 |
| Novolin 70-30 | 11 | $8,929 | $812 |
| Novolin 70-30 Flexpen | 13 | $7,932 | $610 |
| Glipizide Er | 128 | $6,351 | $50 |
| Glimepiride | 261 | $6,166 | $24 |
| Droplet Pen Needle | 63 | $5,197 | $82 |
| Metformin | 300 | $4,519 | $15 |
| Cabergoline | 21 | $3,760 | $179 |
| Glipizide | 239 | $3,635 | $15 |
| Methimazole | 142 | $3,418 | $24 |
| Ultra-Fine Nano Pen Needle | 46 | $3,107 | $68 |
| Hydrocortisone | 49 | $2,361 | $48 |
| Desmopressin Acetate | 16 | $2,216 | $139 |
| Alendronate | 135 | $2,209 | $16 |
| Omega-3 Acid Ethyl Esters | 13 | $1,710 | $132 |
| Atorvastatin | 93 | $1,698 | $18 |
| Gabapentin | 49 | $1,640 | $33 |
| Insulin | 22 | $1,613 | $73 |
| Ultra-Fine Short Pen Needle | 17 | $1,560 | $92 |
| Metformin Hcl Er | 65 | $1,545 | $24 |
| Pravastatin | 53 | $1,462 | $28 |
| Ultra-Fine Mini Pen Needle | 17 | $1,359 | $80 |
| Ulticare Pen Needle | 21 | $1,350 | $64 |
| Simvastatin | 80 | $1,270 | $16 |
| Calcitriol | 23 | $1,240 | $54 |
| Insulin | 36 | $1,216 | $34 |
| Liothyronine | 16 | $963 | $60 |
| Rosuvastatin | 31 | $832 | $27 |
| Losartan | 52 | $761 | $15 |
| Lisinopril | 43 | $611 | $14 |
| Euthyrox | 42 | $537 | $13 |
| Armour Thyroid | 13 | $529 | $41 |
| Benazepril | 22 | $518 | $24 |
| Testosterone Cypionate | 22 | $511 | $23 |
| Pioglitazone | 17 | $488 | $29 |
| Fludrocortisone Acetate | 13 | $478 | $37 |
| Techlite Pen Needle | 12 | $348 | $29 |
| Terazosin | 12 | $334 | $28 |
| Lovastatin | 13 | $311 | $24 |
| Vitamin D2 | 23 | $281 | $12 |
| Amlodipine Besylate | 23 | $256 | $11 |
| Hydrochlorothiazide | 25 | $153 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $146 | $13 |
| Fluconazole | 17 | $136 | $8 |
2021: 77 drugs
| Jardiance | 309 | $361,562 | $1,170 |
| Trulicity | 146 | $244,295 | $1,673 |
| Humalog Mix 75-25 Kwikpen | 102 | $160,180 | $1,570 |
| Lantus Solostar | 253 | $150,319 | $594 |
| Humulin N Kwikpen | 184 | $127,480 | $693 |
| Novolog Flexpen | 126 | $110,042 | $873 |
| Novolog Mix 70-30 Flexpen | 53 | $82,644 | $1,559 |
| Humalog Kwikpen U-100 | 112 | $74,898 | $669 |
| Ozempic | 32 | $70,796 | $2,212 |
| Rybelsus | 30 | $65,950 | $2,198 |
| Januvia | 38 | $47,162 | $1,241 |
| Basaglar Kwikpen U-100 | 79 | $43,177 | $547 |
| Toujeo Solostar | 72 | $40,374 | $561 |
| Novolog | 24 | $39,143 | $1,631 |
| Humalog | 39 | $34,417 | $882 |
| Prolia | 24 | $33,788 | $1,408 |
| Novolin N Flexpen | 71 | $31,702 | $447 |
| Humulin 70-30 | 31 | $31,107 | $1,003 |
| Humalog Mix 75-25 | 19 | $29,298 | $1,542 |
| Insulin Lispro Kwikpen U-100 | 60 | $28,616 | $477 |
| Farxiga | 17 | $27,770 | $1,634 |
| Tresiba Flextouch U-200 | 22 | $25,412 | $1,155 |
| Humulin N | 46 | $24,034 | $522 |
| Tresiba Flextouch U-100 | 37 | $23,758 | $642 |
| Humulin 70/30 Kwikpen | 42 | $21,438 | $510 |
| Lantus | 30 | $20,483 | $683 |
| Levothyroxine | 760 | $18,177 | $24 |
| Victoza 3-Pak | 15 | $16,965 | $1,131 |
| Janumet | 12 | $16,949 | $1,412 |
| Levemir Flextouch | 36 | $16,766 | $466 |
| Invokana | 12 | $14,491 | $1,208 |
| Nano 2nd Gen Pen Needle | 189 | $14,330 | $76 |
| Novolin 70-30 | 19 | $13,897 | $731 |
| Toujeo Max Solostar | 13 | $12,123 | $933 |
| Synthroid | 60 | $7,372 | $123 |
| Glipizide Er | 165 | $6,915 | $42 |
| Glimepiride | 361 | $6,420 | $18 |
| Testosterone | 14 | $5,639 | $403 |
| Ultra-Fine Nano Pen Needle | 60 | $4,609 | $77 |
| Hydrocortisone | 67 | $3,791 | $57 |
| Desmopressin Acetate | 22 | $3,654 | $166 |
| Glipizide | 288 | $2,981 | $10 |
| Metformin | 239 | $2,841 | $12 |
| Cabergoline | 20 | $2,676 | $134 |
| Droplet Pen Needle | 30 | $2,297 | $77 |
| Methimazole | 127 | $2,221 | $17 |
| Calcitriol | 30 | $2,037 | $68 |
| Alendronate | 129 | $1,844 | $14 |
| Ulticare Pen Needle | 35 | $1,808 | $52 |
| Atorvastatin | 92 | $1,578 | $17 |
| Insulin | 23 | $1,425 | $62 |
| Omega-3 Acid Ethyl Esters | 11 | $1,348 | $123 |
| Metformin Hcl Er | 61 | $1,245 | $20 |
| Ultra-Fine Short Pen Needle | 12 | $1,188 | $99 |
| Comfort Ez Pen Needle | 13 | $1,138 | $88 |
| Pen Needles | 15 | $1,063 | $71 |
| Insulin | 23 | $1,062 | $46 |
| Gabapentin | 43 | $1,003 | $23 |
| Pravastatin | 42 | $956 | $23 |
| Testosterone Cypionate | 27 | $783 | $29 |
| Pioglitazone | 32 | $769 | $24 |
| Simvastatin | 60 | $709 | $12 |
| Oxybutynin Chloride | 14 | $694 | $50 |
| Liothyronine | 11 | $653 | $59 |
| Gemfibrozil | 20 | $587 | $29 |
| Euthyrox | 34 | $496 | $15 |
| Losartan | 41 | $417 | $10 |
| Lisinopril | 50 | $374 | $7 |
| Ezetimibe | 13 | $335 | $26 |
| Terazosin | 12 | $312 | $26 |
| Rosuvastatin | 15 | $245 | $16 |
| Benazepril | 11 | $233 | $21 |
| Omeprazole | 15 | $212 | $14 |
| Lovastatin | 13 | $126 | $10 |
| Amlodipine Besylate | 11 | $121 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $108 | $10 |
| Hydrochlorothiazide | 18 | $64 | $4 |
2020: 73 drugs
| Jardiance | 248 | $251,974 | $1,016 |
| Lantus Solostar | 267 | $141,707 | $531 |
| Humalog Mix 75-25 Kwikpen | 93 | $137,485 | $1,478 |
| Humalog Kwikpen U-100 | 96 | $88,041 | $917 |
| Trulicity | 58 | $87,535 | $1,509 |
| Novolog Flexpen | 103 | $86,317 | $838 |
| Humulin N Kwikpen | 116 | $83,168 | $717 |
| Forteo | 14 | $72,067 | $5,148 |
| Januvia | 94 | $70,472 | $750 |
| Novolog Mix 70-30 Flexpen | 35 | $55,406 | $1,583 |
| Novolog | 24 | $50,394 | $2,100 |
| Toujeo Solostar | 80 | $47,826 | $598 |
| Prolia | 30 | $38,764 | $1,292 |
| Basaglar Kwikpen U-100 | 71 | $38,754 | $546 |
| Invokana | 38 | $36,044 | $949 |
| Tresiba Flextouch U-100 | 54 | $34,470 | $638 |
| Ozempic | 19 | $32,609 | $1,716 |
| Humalog Mix 50-50 Kwikpen | 15 | $31,120 | $2,075 |
| Insulin Lispro Kwikpen U-100 | 65 | $29,390 | $452 |
| Tresiba Flextouch U-200 | 26 | $29,245 | $1,125 |
| Humulin 70-30 | 48 | $28,789 | $600 |
| Humalog | 30 | $27,180 | $906 |
| Humalog Mix 75-25 | 18 | $26,165 | $1,454 |
| Farxiga | 18 | $25,370 | $1,409 |
| Victoza 3-Pak | 18 | $25,156 | $1,398 |
| Lantus | 27 | $21,684 | $803 |
| Humulin N | 28 | $18,978 | $678 |
| Janumet | 16 | $18,507 | $1,157 |
| Levothyroxine | 691 | $18,412 | $27 |
| Toujeo Max Solostar | 11 | $17,686 | $1,608 |
| Ultra-Fine Nano Pen Needle | 202 | $13,152 | $65 |
| Humulin 70/30 Kwikpen | 15 | $10,499 | $700 |
| Novolin 70-30 | 14 | $9,343 | $667 |
| Insulin Lispro | 13 | $8,846 | $680 |
| Levemir Flextouch | 22 | $8,295 | $377 |
| Novolin N Flexpen | 17 | $8,214 | $483 |
| Synthroid | 65 | $6,608 | $102 |
| Glimepiride | 355 | $6,101 | $17 |
| Glipizide Er | 156 | $5,722 | $37 |
| Nano 2nd Gen Pen Needle | 65 | $5,537 | $85 |
| Humalog Junior Kwikpen | 11 | $4,448 | $404 |
| Desmopressin Acetate | 24 | $3,130 | $130 |
| Ultra-Fine Mini Pen Needle | 35 | $2,618 | $75 |
| Calcitriol | 37 | $2,575 | $70 |
| Glipizide | 266 | $2,481 | $9 |
| Hydrocortisone | 72 | $2,454 | $34 |
| Methimazole | 112 | $2,355 | $21 |
| Metformin | 224 | $2,345 | $10 |
| Testosterone | 17 | $2,192 | $129 |
| Cabergoline | 15 | $1,859 | $124 |
| Alendronate | 115 | $1,737 | $15 |
| Omega-3 Acid Ethyl Esters | 11 | $1,644 | $149 |
| Ezetimibe | 20 | $1,552 | $78 |
| Metformin Hcl Er | 92 | $1,388 | $15 |
| Liothyronine | 15 | $1,378 | $92 |
| Atorvastatin | 88 | $1,372 | $16 |
| Pravastatin | 54 | $1,272 | $24 |
| Insulin | 27 | $1,002 | $37 |
| Insulin | 16 | $796 | $50 |
| Simvastatin | 75 | $785 | $10 |
| Pioglitazone | 16 | $716 | $45 |
| Ulticare Pen Needle | 18 | $686 | $38 |
| Armour Thyroid | 15 | $602 | $40 |
| Ultra-Fine Short Pen Needle | 12 | $576 | $48 |
| Gabapentin | 24 | $566 | $24 |
| Terazosin | 18 | $540 | $30 |
| Ibandronate | 17 | $491 | $29 |
| Lisinopril | 45 | $326 | $7 |
| Euthyrox | 13 | $280 | $22 |
| Losartan | 20 | $257 | $13 |
| Fludrocortisone Acetate | 12 | $231 | $19 |
| Amlodipine Besylate | 12 | $123 | $10 |
| Metoprolol | 18 | $100 | $6 |
2019: 71 drugs
| Jardiance | 173 | $165,607 | $957 |
| Lantus Solostar | 257 | $128,154 | $499 |
| Humalog Mix 75-25 Kwikpen | 104 | $127,412 | $1,225 |
| Humalog Kwikpen U-100 | 123 | $87,702 | $713 |
| Novolog Mix 70-30 Flexpen | 59 | $75,488 | $1,279 |
| Novolog Flexpen | 94 | $68,936 | $733 |
| Trulicity | 45 | $59,844 | $1,330 |
| Januvia | 43 | $51,502 | $1,198 |
| Humalog Mix 75-25 | 29 | $51,164 | $1,764 |
| Prolia | 38 | $46,795 | $1,231 |
| Invokana | 58 | $46,742 | $806 |
| Basaglar Kwikpen U-100 | 75 | $33,920 | $452 |
| Novolog | 22 | $33,313 | $1,514 |
| Humulin 70-30 | 40 | $31,983 | $800 |
| Tresiba Flextouch U-100 | 56 | $31,592 | $564 |
| Victoza 3-Pak | 23 | $30,032 | $1,306 |
| Humalog | 25 | $28,530 | $1,141 |
| Humalog Mix 50-50 Kwikpen | 11 | $27,192 | $2,472 |
| Ozempic | 14 | $24,058 | $1,718 |
| Humulin N Kwikpen | 44 | $22,309 | $507 |
| Toujeo Solostar | 41 | $21,981 | $536 |
| Tresiba Flextouch U-200 | 16 | $21,337 | $1,334 |
| Lantus | 26 | $20,105 | $773 |
| Farxiga | 19 | $20,066 | $1,056 |
| Tradjenta | 21 | $19,520 | $930 |
| Janumet | 22 | $18,734 | $852 |
| Toujeo Max Solostar | 14 | $17,488 | $1,249 |
| Novolog Mix 70-30 | 19 | $17,026 | $896 |
| Levothyroxine | 616 | $16,779 | $27 |
| Humulin N | 22 | $16,669 | $758 |
| Levemir Flextouch | 32 | $16,634 | $520 |
| Ultra-Fine Nano Pen Needle | 199 | $12,216 | $61 |
| Glimepiride | 392 | $7,640 | $19 |
| Synthroid | 73 | $7,008 | $96 |
| Novolin 70-30 | 13 | $6,149 | $473 |
| Janumet Xr | 11 | $5,821 | $529 |
| Glipizide Er | 113 | $4,922 | $44 |
| Testosterone | 13 | $2,909 | $224 |
| Desmopressin Acetate | 18 | $2,693 | $150 |
| Metformin | 213 | $2,474 | $12 |
| Comfort Ez Pen Needle | 29 | $2,435 | $84 |
| Hydrocortisone | 60 | $2,415 | $40 |
| Liothyronine | 24 | $2,332 | $97 |
| Methimazole | 112 | $2,050 | $18 |
| Glipizide | 217 | $1,974 | $9 |
| Metformin Hcl Er | 100 | $1,851 | $19 |
| Atorvastatin | 90 | $1,623 | $18 |
| Calcitriol | 23 | $1,373 | $60 |
| Pravastatin | 49 | $1,364 | $28 |
| Ezetimibe | 11 | $1,005 | $91 |
| Alendronate | 85 | $998 | $12 |
| Ulticare Pen Needle | 22 | $953 | $43 |
| Glipizide Xl | 21 | $877 | $42 |
| Alcohol Prep Pads | 12 | $858 | $72 |
| Simvastatin | 71 | $844 | $12 |
| Gabapentin | 28 | $825 | $29 |
| Insulin | 30 | $638 | $21 |
| Ultra-Fine Mini Pen Needle | 13 | $624 | $48 |
| Insulin | 18 | $598 | $33 |
| Armour Thyroid | 11 | $575 | $52 |
| Ibandronate | 11 | $568 | $52 |
| Fludrocortisone Acetate | 22 | $498 | $23 |
| Testosterone Cypionate | 17 | $473 | $28 |
| Losartan | 26 | $417 | $16 |
| Lisinopril | 49 | $409 | $8 |
| Terazosin | 17 | $317 | $19 |
| Amlodipine Besylate | 15 | $229 | $15 |
| Spironolactone | 12 | $97 | $8 |
| Omeprazole | 11 | $92 | $8 |
| Metoprolol | 13 | $85 | $7 |
| Hydrochlorothiazide | 20 | $71 | $4 |
2018: 72 drugs
| Humalog Mix 75-25 Kwikpen | 117 | $124,310 | $1,062 |
| Lantus Solostar | 251 | $119,632 | $477 |
| Jardiance | 112 | $101,168 | $903 |
| Humalog Kwikpen U-100 | 109 | $85,940 | $788 |
| Humalog Mix 75-25 | 54 | $80,090 | $1,483 |
| Januvia | 64 | $65,742 | $1,027 |
| Novolog Flexpen | 99 | $64,919 | $656 |
| Prolia | 53 | $62,876 | $1,186 |
| Novolog Mix 70-30 Flexpen | 53 | $60,004 | $1,132 |
| Forteo | 16 | $51,427 | $3,214 |
| Invokana | 64 | $47,773 | $746 |
| Trulicity | 54 | $46,430 | $860 |
| Lantus | 51 | $34,029 | $667 |
| Novolog | 30 | $30,914 | $1,030 |
| Humalog Mix 50-50 | 18 | $28,817 | $1,601 |
| Toujeo Solostar | 49 | $25,920 | $529 |
| Humalog | 28 | $25,322 | $904 |
| Humulin 70-30 | 37 | $24,896 | $673 |
| Novolin 70-30 | 36 | $24,063 | $668 |
| Farxiga | 19 | $22,893 | $1,205 |
| Basaglar Kwikpen U-100 | 51 | $21,351 | $419 |
| Victoza 2-Pak | 16 | $18,612 | $1,163 |
| Tresiba Flextouch U-200 | 30 | $17,522 | $584 |
| Victoza 3-Pak | 19 | $17,514 | $922 |
| Levothyroxine | 671 | $16,314 | $24 |
| Levemir Flextouch | 30 | $15,477 | $516 |
| Humulin N | 27 | $15,264 | $565 |
| Janumet | 22 | $15,149 | $689 |
| Tradjenta | 23 | $14,118 | $614 |
| Ultra-Fine Nano Pen Needle | 254 | $12,823 | $50 |
| Tresiba Flextouch U-100 | 23 | $11,625 | $505 |
| Humalog Mix 50-50 Kwikpen | 11 | $10,649 | $968 |
| Glimepiride | 502 | $10,473 | $21 |
| Humulin N Kwikpen | 13 | $6,805 | $523 |
| Tanzeum | 13 | $6,709 | $516 |
| Synthroid | 82 | $6,230 | $76 |
| Jentadueto | 12 | $5,149 | $429 |
| Glipizide Er | 98 | $4,338 | $44 |
| Metformin | 280 | $2,884 | $10 |
| Metformin Hcl Er | 144 | $2,723 | $19 |
| Hydrocortisone | 72 | $2,383 | $33 |
| Glipizide | 264 | $2,077 | $8 |
| Calcitriol | 24 | $1,618 | $67 |
| Pravastatin | 46 | $1,557 | $34 |
| Desmopressin Acetate | 13 | $1,546 | $119 |
| Methimazole | 111 | $1,526 | $14 |
| Comfort Ez Pen Needle | 19 | $1,489 | $78 |
| Glipizide Xl | 27 | $1,335 | $49 |
| Insulin | 59 | $1,311 | $22 |
| Atorvastatin | 61 | $1,157 | $19 |
| Liothyronine | 22 | $1,132 | $51 |
| Alendronate | 112 | $1,099 | $10 |
| Insulin | 36 | $863 | $24 |
| Veo Insulin | 20 | $735 | $37 |
| Gabapentin | 39 | $690 | $18 |
| Trueplus Pen Needle | 27 | $660 | $24 |
| Comfort Ez Insulin | 11 | $608 | $55 |
| Testosterone Cypionate | 24 | $600 | $25 |
| Simvastatin | 58 | $552 | $10 |
| Ultra-Fine Mini Pen Needle | 13 | $498 | $38 |
| Ultra-Fine Short Pen Needle | 12 | $476 | $40 |
| Lisinopril | 40 | $465 | $12 |
| Gemfibrozil | 15 | $327 | $22 |
| Glyburide | 11 | $296 | $27 |
| Amlodipine Besylate | 13 | $212 | $16 |
| Losartan | 21 | $208 | $10 |
| Enalapril Maleate | 14 | $200 | $14 |
| Terazosin | 12 | $163 | $14 |
| Hydrochlorothiazide | 18 | $157 | $9 |
| Spironolactone | 14 | $94 | $7 |
| Prednisone | 14 | $87 | $6 |
| Omeprazole | 13 | $36 | $3 |
2017: 68 drugs
| Lantus Solostar | 163 | $90,131 | $553 |
| Humalog Mix 75-25 Kwikpen | 84 | $89,953 | $1,071 |
| Humalog Kwikpen U-100 | 127 | $89,059 | $701 |
| Invokana | 125 | $73,883 | $591 |
| Novolog Mix 70-30 Flexpen | 63 | $58,768 | $933 |
| Prolia | 47 | $50,915 | $1,083 |
| Novolog | 45 | $50,817 | $1,129 |
| Humalog Mix 50-50 | 25 | $47,851 | $1,914 |
| Jardiance | 58 | $46,342 | $799 |
| Humalog Mix 75-25 | 28 | $45,438 | $1,623 |
| Januvia | 69 | $42,585 | $617 |
| Forteo | 13 | $38,141 | $2,934 |
| Toujeo Solostar | 70 | $34,973 | $500 |
| Victoza 3-Pak | 41 | $34,364 | $838 |
| Humulin 70-30 | 67 | $33,968 | $507 |
| Metformin Hcl Er | 190 | $30,114 | $158 |
| Lantus | 36 | $27,848 | $774 |
| Novolin 70-30 | 53 | $26,275 | $496 |
| Humalog | 41 | $25,602 | $624 |
| Victoza 2-Pak | 23 | $21,085 | $917 |
| Humulin R U-500 Kwikpen | 11 | $20,695 | $1,881 |
| Novolog Flexpen | 26 | $20,441 | $786 |
| Humulin N | 59 | $19,931 | $338 |
| Humalog Kwikpen U-200 | 13 | $16,562 | $1,274 |
| Farxiga | 22 | $16,108 | $732 |
| Levothyroxine | 737 | $14,330 | $19 |
| Ultra-Fine Nano Pen Needle | 253 | $11,569 | $46 |
| Bydureon | 12 | $10,890 | $908 |
| Sensipar | 12 | $10,648 | $887 |
| Glimepiride | 632 | $10,387 | $16 |
| Janumet | 22 | $9,597 | $436 |
| Tresiba Flextouch U-200 | 13 | $7,036 | $541 |
| Synthroid | 95 | $6,309 | $66 |
| Levemir Flextouch | 14 | $5,757 | $411 |
| Novolin N | 15 | $3,265 | $218 |
| Glipizide Er | 99 | $2,912 | $29 |
| Metformin | 326 | $2,619 | $8 |
| Humulin R | 13 | $2,150 | $165 |
| Insulin | 57 | $1,874 | $33 |
| Insulin | 96 | $1,797 | $19 |
| Cabergoline | 16 | $1,760 | $110 |
| Glipizide | 258 | $1,586 | $6 |
| Methimazole | 120 | $1,374 | $11 |
| Hydrocortisone | 58 | $1,279 | $22 |
| Pravastatin | 35 | $1,222 | $35 |
| Alendronate | 160 | $1,089 | $7 |
| Comfort Ez | 14 | $859 | $61 |
| Gabapentin | 60 | $786 | $13 |
| Glipizide Xl | 26 | $692 | $27 |
| Ulticare Pen Needle | 25 | $601 | $24 |
| Fenofibrate | 15 | $573 | $38 |
| Liothyronine | 18 | $570 | $32 |
| Atorvastatin | 40 | $567 | $14 |
| Pen Needles | 11 | $565 | $51 |
| Gemfibrozil | 31 | $369 | $12 |
| Simvastatin | 64 | $362 | $6 |
| Lisinopril | 42 | $257 | $6 |
| Repaglinide | 11 | $246 | $22 |
| Amiloride | 12 | $239 | $20 |
| Insulin | 16 | $239 | $15 |
| Fludrocortisone Acetate | 11 | $204 | $19 |
| Glyburide | 13 | $184 | $14 |
| Amlodipine Besylate | 35 | $177 | $5 |
| Losartan | 21 | $110 | $5 |
| Terazosin | 13 | $60 | $5 |
| Spironolactone | 15 | $46 | $3 |
| Hydrochlorothiazide | 11 | $42 | $4 |
| Dexamethasone | 15 | $40 | $3 |
2016: 65 drugs
| Humalog Mix 75-25 Kwikpen | 102 | $116,566 | $1,143 |
| Novolog Mix 70-30 Flexpen | 122 | $102,224 | $838 |
| Lantus Solostar | 142 | $67,939 | $478 |
| Invokana | 112 | $59,463 | $531 |
| Forteo | 19 | $46,864 | $2,467 |
| Prolia | 44 | $44,848 | $1,019 |
| Januvia | 110 | $41,824 | $380 |
| Humalog Mix 50-50 Kwikpen | 22 | $40,269 | $1,830 |
| Novolin 70-30 | 101 | $38,621 | $382 |
| Novolog Flexpen | 70 | $38,320 | $547 |
| Humalog Kwikpen U-100 | 67 | $35,219 | $526 |
| Novolog | 43 | $31,877 | $741 |
| Lantus | 47 | $27,377 | $582 |
| Humulin 70-30 | 57 | $24,184 | $424 |
| Humalog | 37 | $23,283 | $629 |
| Humalog Mix 75-25 | 30 | $23,097 | $770 |
| Victoza 3-Pak | 26 | $19,951 | $767 |
| Toujeo Solostar | 42 | $18,307 | $436 |
| Jardiance | 38 | $15,282 | $402 |
| Humalog Mix 50-50 | 12 | $15,202 | $1,267 |
| Androgel | 24 | $14,738 | $614 |
| Bydureon | 14 | $13,146 | $939 |
| Bd Ultra-Fine Pen Needle | 291 | $12,851 | $44 |
| Levothyroxine | 675 | $10,661 | $16 |
| Sensipar | 12 | $9,579 | $798 |
| Farxiga | 21 | $8,845 | $421 |
| Glimepiride | 670 | $8,679 | $13 |
| Tradjenta | 19 | $8,416 | $443 |
| Humulin 70/30 Kwikpen | 14 | $7,152 | $511 |
| Janumet | 21 | $6,980 | $332 |
| Humulin N | 25 | $6,392 | $256 |
| Levemir Flextouch | 21 | $6,133 | $292 |
| Synthroid | 120 | $6,077 | $51 |
| Metformin Hcl Er | 146 | $4,722 | $32 |
| Novolog Mix 70-30 | 16 | $3,919 | $245 |
| Cabergoline | 35 | $3,038 | $87 |
| Metformin | 306 | $2,227 | $7 |
| Glipizide | 290 | $1,606 | $6 |
| Insulin | 52 | $1,586 | $30 |
| Insulin | 72 | $1,468 | $20 |
| Nateglinide | 12 | $1,341 | $112 |
| Methimazole | 120 | $1,195 | $10 |
| Fenofibrate | 15 | $1,177 | $78 |
| Pravastatin | 49 | $987 | $20 |
| Glipizide Er | 54 | $842 | $16 |
| Comfort Ez | 15 | $704 | $47 |
| Calcitriol | 12 | $700 | $58 |
| Hydrocortisone | 37 | $688 | $19 |
| Insulin | 28 | $665 | $24 |
| Alendronate | 106 | $637 | $6 |
| Ibandronate | 15 | $560 | $37 |
| Propylthiouracil | 12 | $527 | $44 |
| Glipizide Xl | 21 | $492 | $23 |
| Unifine Pentips | 17 | $471 | $28 |
| Simvastatin | 74 | $409 | $6 |
| Atorvastatin | 23 | $286 | $12 |
| Losartan | 47 | $276 | $6 |
| Lisinopril | 50 | $246 | $5 |
| Glyburide | 17 | $196 | $12 |
| Amlodipine Besylate | 23 | $150 | $7 |
| Gabapentin | 30 | $125 | $4 |
| Gemfibrozil | 15 | $105 | $7 |
| Hydrochlorothiazide | 19 | $89 | $5 |
| Dexamethasone | 24 | $85 | $4 |
| Terazosin | 13 | $70 | $5 |
2015: 61 drugs
| Novolog Mix 70-30 Flexpen | 95 | $99,887 | $1,051 |
| Forteo | 32 | $63,201 | $1,975 |
| Humalog Mix 75-25 Kwikpen | 90 | $52,609 | $585 |
| Invokana | 109 | $48,411 | $444 |
| Lantus Solostar | 95 | $41,627 | $438 |
| Januvia | 103 | $39,694 | $385 |
| Humulin 70-30 | 88 | $34,568 | $393 |
| Humalog Mix 75-25 | 29 | $29,334 | $1,012 |
| Novolog Flexpen | 63 | $28,662 | $455 |
| Humalog Mix 50-50 | 27 | $28,533 | $1,057 |
| Humalog Mix 50-50 Kwikpen | 15 | $26,228 | $1,749 |
| Prolia | 25 | $23,916 | $957 |
| Humalog Kwikpen U-100 | 40 | $20,355 | $509 |
| Humalog | 27 | $18,960 | $702 |
| Bydureon | 27 | $17,792 | $659 |
| Novolin 70-30 | 70 | $16,334 | $233 |
| Novolog | 26 | $16,030 | $617 |
| Victoza 3-Pak | 24 | $15,017 | $626 |
| Androgel | 28 | $13,008 | $465 |
| Tradjenta | 33 | $11,834 | $359 |
| Victoza 2-Pak | 18 | $10,940 | $608 |
| Bd Ultra-Fine Pen Needle | 236 | $10,784 | $46 |
| Lantus | 22 | $10,520 | $478 |
| Novolog Mix 70-30 | 18 | $9,647 | $536 |
| Levemir Flextouch | 29 | $8,240 | $284 |
| Levothyroxine | 424 | $7,645 | $18 |
| Jardiance | 21 | $7,442 | $354 |
| Cabergoline | 43 | $5,414 | $126 |
| Glimepiride | 447 | $5,394 | $12 |
| Synthroid | 123 | $5,122 | $42 |
| Farxiga | 12 | $4,160 | $347 |
| Crestor | 12 | $3,309 | $276 |
| Repaglinide | 11 | $2,496 | $227 |
| Metformin | 269 | $2,479 | $9 |
| Insulin | 83 | $1,997 | $24 |
| Fenofibrate | 23 | $1,930 | $84 |
| Methimazole | 116 | $1,699 | $15 |
| Metformin Hcl Er | 69 | $979 | $14 |
| Pravastatin | 53 | $926 | $17 |
| Insulin | 43 | $870 | $20 |
| Insulin | 20 | $633 | $32 |
| Comfort Ez | 15 | $623 | $42 |
| Glipizide | 100 | $607 | $6 |
| Atorvastatin | 25 | $539 | $22 |
| Testosterone Cypionate | 11 | $476 | $43 |
| Simvastatin | 62 | $435 | $7 |
| Alendronate | 61 | $410 | $7 |
| Hydrocortisone | 21 | $316 | $15 |
| Unifine Pentips | 12 | $311 | $26 |
| Lisinopril | 49 | $309 | $6 |
| Glipizide Xl | 20 | $291 | $15 |
| Glyburide | 18 | $278 | $15 |
| Propylthiouracil | 11 | $277 | $25 |
| Glipizide Er | 11 | $276 | $25 |
| Losartan | 40 | $238 | $6 |
| Tamsulosin | 11 | $206 | $19 |
| Gabapentin | 22 | $156 | $7 |
| Valsartan-Hydrochlorothiazide | 11 | $153 | $14 |
| Pen Needle | 11 | $142 | $13 |
| Hydrochlorothiazide | 21 | $139 | $7 |
| Terazosin | 23 | $110 | $5 |
2014: 41 drugs
| Novolog Mix 70-30 Flexpen | 29 | $35,351 | $1,219 |
| Humalog Mix 50-50 | 39 | $30,701 | $787 |
| Humalog Mix 75-25 | 63 | $28,663 | $455 |
| Lantus Solostar | 79 | $27,775 | $352 |
| Lantus | 58 | $20,293 | $350 |
| Forteo | 12 | $18,857 | $1,571 |
| Bydureon | 34 | $16,715 | $492 |
| Invokana | 48 | $16,631 | $346 |
| Humulin 70-30 | 55 | $15,265 | $278 |
| Prolia | 13 | $11,857 | $912 |
| Novolog Flexpen | 30 | $11,854 | $395 |
| Humalog | 17 | $7,681 | $452 |
| Januvia | 16 | $5,478 | $342 |
| Tradjenta | 17 | $5,216 | $307 |
| Victoza 2-Pak | 13 | $5,068 | $390 |
| Bd Ultra-Fine Pen Needle | 115 | $4,930 | $43 |
| Byetta | 11 | $4,887 | $444 |
| Novolin 70-30 | 26 | $4,817 | $185 |
| Novolog | 14 | $4,623 | $330 |
| Levemir | 12 | $3,025 | $252 |
| Levothyroxine | 125 | $2,121 | $17 |
| Synthroid | 52 | $2,084 | $40 |
| Insulin | 70 | $1,374 | $20 |
| Metformin | 156 | $1,295 | $8 |
| Pravastatin | 53 | $1,084 | $20 |
| Insulin | 32 | $733 | $23 |
| Atorvastatin | 30 | $716 | $24 |
| Glimepiride | 66 | $661 | $10 |
| Methimazole | 31 | $638 | $21 |
| Hydrocortisone | 27 | $547 | $20 |
| Metformin Hcl Er | 22 | $327 | $15 |
| Spironolactone | 11 | $240 | $22 |
| Alendronate | 26 | $218 | $8 |
| Gabapentin | 21 | $213 | $10 |
| Glipizide | 32 | $192 | $6 |
| Simvastatin | 15 | $146 | $10 |
| Hydrochlorothiazide | 31 | $134 | $4 |
| Glipizide Xl | 14 | $119 | $8 |
| Losartan | 11 | $78 | $7 |
| Lisinopril | 14 | $66 | $5 |
| Furosemide | 12 | $48 | $4 |
2013: 4 drugs
| Lantus | 15 | $5,329 | $355 |
| Synthroid | 16 | $620 | $39 |
| Metformin | 25 | $360 | $14 |
| Levothyroxine | 19 | $260 | $14 |
Money from drug and device companies
$86 in 2025
| 2025 | 1 | 1 | None | $86 |
| 2024 | 3 | 3 | None | $257 |
| 2023 | 1 | 4 | None | $65 |
| 2022 | 1 | 4 | None | $74 |
| 2021 | 2 | 2 | None | $32 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $86 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-03-26 | Ozempic | $86 |
See earlier years (2024, 2023, 2022, 2021)
2024: $257
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $118 | 1 payment
|
| Novo Nordisk | Wegovy | $118 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $21 | 1 payment
|
2023: $65
| Novo Nordisk | Rybelsus | $65 | 4 payments
|
2022: $74
| Novo Nordisk | Ozempic | $74 | 4 payments
|
2021: $32
| Medtronic | Minimed 770g System | $18 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
Professional record
- NPI
- 1215025465
- Licence
- CA A125244California A125244: Current · expires 2027-04-30
- Trained
- University of Florida College of Medicine, 2004 · 22 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- 1541 Florida Ave, Ste #200, Modesto, CA, 95350
- NPI first listed
- 2006-10-11
- NPI last updated
- 2013-06-27
This is when the NPI record was last certified, not a medical board exam.